JBF Capital’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
JBF Capital's SCPH Position: Q4 2025 in Review
JBF Capital sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 135,000 shares — an estimated $765K sold.
JBF Capital first reported a position in SCPH in Q3 2025 and held it in 1 quarter. The position peaked at $765K in Q3 2025. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.
- JBF Capital reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
- JBF Capital sold 135,000 scPharmaceuticals shares in Q4 2025, an estimated $765K.
- JBF Capital first reported a position in scPharmaceuticals in Q3 2025 and held it in 1 quarter.
- JBF Capital's scPharmaceuticals position peaked at $765K in Q3 2025.
- 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.
Based on JBF Capital's 13F filing for Q4 2025, filed 12 Feb 2026.